Insider Selling: Kestra Medical Technologies (NASDAQ:KMTS) Insider Sells 15,000 Shares of Company Stock

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) insider Brian Webster sold 15,000 shares of Kestra Medical Technologies stock in a transaction that occurred on Tuesday, October 20th. The shares were sold at an average price of $29.56, for a total value of $443,400.00. Following the sale, the insider directly owned 445,215 shares in the company, valued at $13,160,555.40. The trade was a 3.26% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link.

Brian Daniel Webster also recently made the following trade(s):

• On Monday, August 17th, Brian Webster sold 15,000 shares of Kestra Medical Technologies stock. The stock was sold at an average price of $27.48, for a total value of $412,200.00.
• On Tuesday, August 4th, Brian Webster sold 51,900 shares of Kestra Medical Technologies stock. The stock was sold at an average price of $24.52, for a total value of $1,272,588.00.
• On Monday, August 3rd, Brian Webster sold 13,017 shares of Kestra Medical Technologies stock. The shares were sold at an average price of $23.92, for a total value of $311,366.64.
• On Friday, July 31st, Brian Webster sold 8,948 shares of Kestra Medical Technologies stock. The shares were sold at an average price of $22.60, for a total value of $202,224.80.
• On Thursday, July 30th, Brian Webster sold 7,857 shares of Kestra Medical Technologies stock. The stock was sold at an average price of $22.72, for a total value of $178,511.04.

Kestra Medical Technologies Price Performance

Kestra Medical Technologies stock traded up $1.01 during mid-day trading on Thursday, hitting $28.32. 739,134 shares of the company were exchanged, compared to its average volume of 349,841. The company has a market capitalization of $1.69 billion, a PE ratio of -10.61 and a beta of 0.51. The business has a fifty day moving average of $26.40 and a 200 day moving average of $23.73. Kestra Medical Technologies, Ltd. has a 1-year low of $17.34 and a 1-year high of $30.00. The company has a quick ratio of 4.69, a current ratio of 4.69 and a debt-to-equity ratio of 0.33.

Kestra Medical Technologies (NASDAQ:KMTS) last issued its earnings results on Monday, September 14th. The company reported ($0.75) EPS for the quarter, missing the consensus estimate of ($0.61) by ($0.14). Kestra Medical Technologies had a negative net margin of 140.43% and a negative return on equity of 63.83%. The firm had revenue of $30.97 million during the quarter. As a group, sell-side analysts expect that Kestra Medical Technologies, Ltd. will post -2.45 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on KMTS shares. Weiss Ratings raised shares of Kestra Medical Technologies from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, September 16th. Wolfe Research set a $30.00 price objective on shares of Kestra Medical Technologies in a research note on Wednesday, July 15th. BTIG Research reaffirmed a “buy” rating and set a $32.00 price objective on shares of Kestra Medical Technologies in a report on Tuesday, September 15th. Wall Street Zen cut shares of Kestra Medical Technologies from a “hold” rating to a “sell” rating in a research note on Saturday, September 12th. Finally, Evercore began coverage on Kestra Medical Technologies in a report on Tuesday. They issued an “outperform” rating and a $34.00 target price on the stock. Five analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $29.00.

Institutional Trading of Kestra Medical Technologies

Several hedge funds have recently modified their holdings of KMTS. Corient Private Wealth LP increased its holdings in shares of Kestra Medical Technologies by 284.2% in the second quarter. Corient Private Wealth LP now owns 60,614 shares of the company’s stock valued at $1,542,000 after purchasing an additional 44,839 shares in the last quarter. Sei Investments Co. raised its position in Kestra Medical Technologies by 22.6% in the 1st quarter. Sei Investments Co. now owns 237,116 shares of the company’s stock worth $4,726,000 after purchasing an additional 43,753 shares during the last quarter. Spartan Wealth Advisory Services LLC acquired a new position in Kestra Medical Technologies during the 1st quarter worth $603,000. Bank of New York Mellon Corp lifted its holdings in Kestra Medical Technologies by 47.2% during the 1st quarter. Bank of New York Mellon Corp now owns 70,113 shares of the company’s stock worth $1,397,000 after buying an additional 22,471 shares in the last quarter. Finally, Quantinno Capital Management LP acquired a new position in Kestra Medical Technologies during the 1st quarter worth $431,000.

About Kestra Medical Technologies

Kestra Medical Technologies, Inc is a medical technology company focused on developing and commercializing wearable solutions for patients at risk of sudden cardiac arrest. Its primary product is the ASSURE wearable cardioverter defibrillator, a wearable device designed to continuously monitor a patient’s heart rhythm and deliver a therapeutic shock when clinically necessary.

The company’s platform combines cardiac monitoring, arrhythmia detection and defibrillation capabilities in a wearable system intended for use outside the hospital.